These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32691478)

  • 41. Screening young adult cancer survivors for depression and anxiety with the Primary Care Evaluation of Mental Disorders (PRIME-MD): Comparisons with a structured clinical diagnostic interview.
    Chevalier LL; Blackmon JE; Roman A; Chang G; Recklitis CJ
    Psychooncology; 2023 Jul; 32(7):1122-1129. PubMed ID: 37221443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. More anxious or more shy? Examining the social anxiety levels of adolescents with primary enuresis nocturna: a controlled study.
    Eray Ş; Tekcan D; Baran Y
    J Pediatr Urol; 2019 Aug; 15(4):343.e1-343.e5. PubMed ID: 31036479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability and Validity of the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Portuguese Version.
    Marques CC; Matos AP; do Céu Salvador M; Arnarson EÖ; Craighead WE
    Child Psychiatry Hum Dev; 2022 Dec; 53(6):1119-1128. PubMed ID: 34050391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for depression in acute coronary syndrome patients: A comparison of Patient Health Questionnaire-9 versus Hospital Anxiety and Depression Scale-Depression.
    Yuan J; Ding R; Wang L; Sheng L; Li J; Hu D
    J Psychosom Res; 2019 Jun; 121():24-28. PubMed ID: 30928210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).
    Sheehan DV; Sheehan KH; Shytle RD; Janavs J; Bannon Y; Rogers JE; Milo KM; Stock SL; Wilkinson B
    J Clin Psychiatry; 2010 Mar; 71(3):313-26. PubMed ID: 20331933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity and screening properties of three depression rating scales in a prospective sample of patients with severe traumatic brain injury.
    Schwarzbold ML; Diaz AP; Nunes JC; Sousa DS; Hohl A; Guarnieri R; Linhares MN; Walz R
    Braz J Psychiatry; 2014 Sep; 36(3):206-12. PubMed ID: 24770656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic operating characteristics of PROMIS scales in screening for depression.
    Kroenke K; Stump TE; Kean J; Krebs EE; Damush TM; Bair MJ; Monahan PO
    J Psychosom Res; 2021 Aug; 147():110532. PubMed ID: 34052655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different Clinical Expression of Anxiety Disorders in Children and Adolescents: Assessment and Treatment.
    Pop-Jordanova N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):5-40. PubMed ID: 31152643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in Zambia.
    Mbewe EK; Uys LR; Nkwanyana NM; Birbeck GL
    Epilepsy Behav; 2013 May; 27(2):296-300. PubMed ID: 23510742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients.
    Annunziata MA; Muzzatti B; Bidoli E; Flaiban C; Bomben F; Piccinin M; Gipponi KM; Mariutti G; Busato S; Mella S
    Support Care Cancer; 2020 Aug; 28(8):3921-3926. PubMed ID: 31858249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychometric properties and validation of the Spanish versions of the overall anxiety and depression severity and impairment scales.
    Osma J; Quilez-Orden A; Suso-Ribera C; Peris-Baquero O; Norman SB; Bentley KH; Sauer-Zavala S
    J Affect Disord; 2019 Jun; 252():9-18. PubMed ID: 30953927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Convergent and divergent validity of K-SADS-PL anxiety and attention deficit hyperactivity disorder diagnoses in a clinical sample of school-aged children.
    Villabø MA; Oerbeck B; Skirbekk B; Hansen BH; Kristensen H
    Nord J Psychiatry; 2016 Jul; 70(5):358-64. PubMed ID: 26836986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The validity of the hospital anxiety and depression scale and the geriatric depression scale-5 in home-dwelling old adults in Norway
    Eriksen S; Bjørkløf GH; Helvik AS; Larsen M; Engedal K
    J Affect Disord; 2019 Sep; 256():380-385. PubMed ID: 31212233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of the Anxiety, Depression and Coping (ADAF) screening tool for emotional and coping problems in cancer patients.
    Pérez-Segura P; Enrech Francés S; Juez Martel I; Pérez Escutia MA; Hernández Agudo E; Leon L; Corradi G; Olivera Pérez-Frade H; Sánchez Escamilla F; Baselga López M; Baquero JL; Redondo Delgado M
    Psychooncology; 2021 Nov; 30(11):1894-1901. PubMed ID: 34197018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory.
    Preljevic VT; Østhus TB; Sandvik L; Opjordsmoen S; Nordhus IH; Os I; Dammen T
    J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validating the Patient-Reported Outcomes Measurement Information System Short Form v1.0-Anxiety 8a in a sample of young adult cancer survivors: Comparison with a structured clinical diagnostic interview.
    Recklitis CJ; Blackmon JE; Chevalier LL; Chang G
    Cancer; 2021 Oct; 127(19):3691-3697. PubMed ID: 34196978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Posttraumatic stress disorder among mothers of pediatric cancer survivors: diagnosis, comorbidity, and utility of the PTSD checklist as a screening instrument.
    Manne SL; Du Hamel K; Gallelli K; Sorgen K; Redd WH
    J Pediatr Psychol; 1998 Dec; 23(6):357-66. PubMed ID: 9824924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4).
    Renovanz M; Soebianto S; Tsakmaklis H; Keric N; Nadji-Ohl M; Beutel M; Ringel F; Wollschläger D; Hickmann AK
    Support Care Cancer; 2019 Dec; 27(12):4469-4477. PubMed ID: 30904948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
    Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
    Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outpatient clinic-wide psychological screening for children and adolescents with type 1 diabetes in Qatar: An initiative for integrative healthcare in the Gulf region.
    Vlahou CH; Petrovski G; Korayem M; Al Khalaf F; El Awwa A; Mahmood OM; Azeem MW
    Pediatr Diabetes; 2021 Jun; 22(4):667-674. PubMed ID: 33715298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.